Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidisIris Valdés, Gerardo Guillén, Lisset Hermida et al.|Vaccine|2008Cited by 47
Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: A road map for discovering new antigensJeovanis Gil, Vladimir Besada, Lázaro Betancourt et al.|Human Vaccines|2009Cited by 26
Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human useIris Valdés, Gerardo Guillén, Lisset Hermida et al.|International Journal of Infectious Diseases|2009Cited by 26
Immunogenicity of recombinant class 1 protein from Neisseria meningitidis refolded into phospholipid vesicles and detergentOlivia Niebla, Gerardo Guillén, Anabel Álvarez et al.|Vaccine|2001Cited by 13
Cloning and expression of the <i>porA</i> gene of the <i>Neisseria meningitidis</i> strain B : 4 : P1.15 in <i>Escherichia coli</i>. Preliminary characterization of the recombinant polypeptideGerardo Guillén, Luís Herrera, Alain Bolaño Alvarez et al.|Acta Biotechnologica|1996Cited by 3